| Literature DB >> 11343123 |
A Tafuri1, A Shahinian, F Bladt, S K Yoshinaga, M Jordana, A Wakeham, L M Boucher, D Bouchard, V S Chan, G Duncan, B Odermatt, A Ho, A Itie, T Horan, J S Whoriskey, T Pawson, J M Penninger, P S Ohashi, T W Mak.
Abstract
The outcome of T-cell responses after T-cell encounter with specific antigens is modulated by co-stimulatory signals, which are required for both lymphocyte activation and development of adaptive immunity. ICOS, an inducible co-stimulator with homology to CD28, is expressed on activated, but not resting T cells, and shows T-cell co-stimulatory function in vitro. ICOS binds specifically to its counter-receptor B7RP-1 (refs 5,6,7), but not to B7-1 or B7-2. Here we provide in vivo genetic evidence that ICOS delivers a co-stimulatory signal that is essential both for efficient interaction between T and B cells and for normal antibody responses to T-cell-dependent antigens. To determine the physiological function of ICOS, we generated and characterized gene-targeted ICOS-deficient mice. In vivo, a lack of ICOS results in severely deficient T-cell-dependent B-cell responses. Germinal centre formation is impaired and immunoglobulin class switching, including production of allergy-mediating IgE, is defective. ICOS-deficient T cells primed in in vivo and restimulated in vitro with specific antigen produce only low levels of interleukin-4, but remain fully competent to produce interferon-gamma.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11343123 DOI: 10.1038/35051113
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962